Rose Abigail, Peters Nikki, Shea Judy A, Armstrong Katrina
University of Pennsylvania, Philadelphia, Pennsylvania, and Center for Health Equity Research and Promotion, Philadelphia VA Medical Center, Pennsylvania, PA 19104-6021, USA.
J Health Commun. 2005 Jun;10(4):309-21. doi: 10.1080/10810730590950039.
Attitudes about genetic testing are likely to be an important determinant of uptake of predictive genetic tests among the general public. Several prior studies have suggested that positive attitudes about genetic testing may be inversely related to knowledge about genetic testing. We conducted a random-digit-dialing (RDD) telephone survey of 961 adults in the continental United States to determine the associations among knowledge of, attitudes about, and perceptions of eligibility for genetic testing for cancer risk. Knowledge about genetic testing for cancer risk was generally high, with a mean accuracy score of 72%. Attitudes about genetic testing for cancer risk were also generally positive, with 87% of respondents reporting genetic testing for cancer risk would be used to help doctors manage their health care and 85% to help scientists find cures for diseases. In contrast, 58% of respondents thought genetic testing for cancer risk would be used to prevent them from getting health insurance and 31% to allow the government to label groups as inferior. Twenty-nine percent of respondents thought they were currently eligible for testing. After adjustment for sociodemographic characteristics and family cancer history, higher knowledge was correlated with more positive attitudes about testing, but not with negative attitudes or perceptions of testing eligibility. Family history was positively associated with perceptions of eligibility (OR 3.49, 95% CI 2.36-5.18), and higher levels of education were inversely associated with perceptions of eligibility (OR 0.55, 95% CI 0.32-0.94 for comparison of college or higher vs. less than high school). These results suggest that most members of the general public are knowledgeable and have positive attitudes about genetic testing for cancer risk and that greater knowledge is correlated with more positive attitudes about the benefits of testing.
对于基因检测的态度可能是普通公众接受预测性基因检测的一个重要决定因素。此前的几项研究表明,对基因检测持积极态度可能与基因检测知识呈负相关。我们对美国大陆的961名成年人进行了随机数字拨号(RDD)电话调查,以确定癌症风险基因检测的知识、态度和资格认知之间的关联。关于癌症风险基因检测的知识普遍较高平均准确率为72%。对癌症风险基因检测的态度也普遍积极,87%的受访者表示癌症风险基因检测将用于帮助医生管理他们的医疗保健,85%的受访者表示将有助于科学家找到疾病的治愈方法。相比之下,58%的受访者认为癌症风险基因检测将被用于阻止他们获得医疗保险,31%的受访者认为会让政府将某些群体标记为低等群体。29%的受访者认为他们目前有资格接受检测。在调整了社会人口学特征和家族癌症病史后,更高的知识水平与对检测更积极的态度相关,但与消极态度或检测资格认知无关。家族病史与资格认知呈正相关(比值比3.49,95%置信区间2.36 - 5.18),而较高的教育水平与资格认知呈负相关(大学及以上学历与高中以下学历相比,比值比0.55,95%置信区间0.32 - 0.94)。这些结果表明,大多数普通公众对癌症风险基因检测有一定了解且持积极态度,并且更多的知识与对检测益处更积极的态度相关。